Evaluating the Efficacy of Gut Microbiome Modulation through Synbiotic Formulations in Managing Obesity-Induced Systemic Inflammation
Keywords:
synbiotics, obesity, systemic inflammation, gut microbiota, metabolic endotoxemia, SCFA, CRP, IL-6, TNF-αAbstract
Obesity is characterized by chronic, low-grade systemic inflammation driven in part by gut microbiome dysbiosis and metabolic endotoxemia. Synbiotics—purposeful combinations of probiotics and prebiotics—aim to restore microbial ecology and increase anti-inflammatory metabolites (e.g., short-chain fatty acids, SCFAs). Here we synthesize evidence and present a concise, synthetic data demonstration from a hypothetical 12-week randomized controlled trial (RCT) to illustrate effect sizes commonly reported in the literature. The demonstration shows greater reductions in C-reactive protein (CRP), IL-6, TNF-α, and lipopolysaccharide (LPS) with synbiotics versus placebo, alongside improved HOMA-IR and SCFA levels. Collectively, historical RCTs and meta-analyses suggest synbiotics can modestly attenuate obesity-related inflammation, though effects depend on strain–fiber matching, dose, baseline phenotype, and diet. More standardized, adequately powered trials with harmonized biomarker panels are warranted.
References
[1] Hibberd AA, Yde CC, Ziegler ML, Honoré AH, Saarinen MT, Lahtinen S, Stahl B, Jensen HM, Stenman LK (2019) Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults. Beneficial Microbes 10(2):121–135.
[2] Kelishadi R, Farajian S, Safavi M, Mirlohi M, Hashemipour M (2014) A randomized triple-masked controlled trial on the effects of synbiotics on inflammation markers in overweight children. J Pediatr (Rio J) 90(2):161–168.
[3] Zhuang Z, et al. (2023) Exploring the role of gut microbiota in obesity. Nutrients 15(21):4697.
[4] Green M, Arora K, Prakash S (2020) Prebiotic and probiotic functional foods to target obesity and metabolic syndrome. Nutrients 12(4):1063.
[5] Geng J, Wang B (2022) The links between gut microbiota and obesity with key metabolites and signaling pathways. Anaerobe 74:102536.
[6] Ecklu-Mensah G, et al. (2023) Gut microbiota and fecal short-chain fatty acids differ with obesity and country. Nature Communications 14:5298.
[7] Du Y, et al. (2024) The role of short-chain fatty acids in inflammation and immune system. Frontiers in Immunology 15:1350260.
[8] Lyon J III, et al. (2023) Effect of synbiotics on weight loss and metabolic health in individuals engaged in lifestyle modification. Obesity 31(10):2012–2020.
[9] Niu X, et al. (2024) Effect of synbiotic supplementation on obesity and gut microbiota: a randomized controlled trial. Frontiers in Nutrition 11:1510318.
[10] Musazadeh V, et al. (2024) The effect of synbiotics on liver enzymes, obesity indices, and inflammatory cytokines in NAFLD: systematic review and meta-analysis. Nutrition Research 124:1–12.
[11] Rasaei N, et al. (2024) The effects of prebiotic, probiotic or synbiotic supplementation on obesity-related indicators: meta-analysis. BMC Complement Med Ther 24:200.
[12] Soltani S, et al. (2023) Effects of probiotic/synbiotic supplementation on body weight and BMI in adults with diabetes: systematic review and meta-analysis. BMC Endocrine Disorders 23:196.
